References

 

Home • AltMed Home • Search

Home

 

 

 

Almedia JC, Grimsley EW.  Coma From the Health Food Store:  Interaction between Kava and
         Alprazolam (Letter).  Ann Intern Med 1996; 125: 940-1.
 

American Society of Anesthesiology. Considerations for Anesthesiologists: What you should know about your patients use

         of herbal medicines and other dietary supplements.  2003.

 

Ang-Lee MK, Moss J, Yuan CS.  Herbal Medicines and Perioperative Care.  JAMA 2001; 286(2): 208-16.
 

Brem AS.  Insights Into Glucocorticoid-Associated Hypertension.  Am J of Kidney Diseases 2001; 37(1).
 

Cheng, B, Hung, CT, Chiu, W.  Herbal Medicine and Anesthesia.  Hong Kong Medical Journal. 2002. 8(2):123-130.

 

Cupp MJ.  Herbal Remedies:  Adverse Effects and Drug Interactions.  American Family Physician 1999;
         59(5).
 

Dietary Supplement Database. http://meded.ucsd.edu/isp/2003/thomas/index.html

 

Earnst E, Pittler MH.  Prevalence of Herbal Medicine in North America.  Med Clin N America 2002; 86(1).
 

Eriksson JW.  Life-threatening Ventricular Tachycardia Due to Liquorice-induced Hypokalemia.  J Intern
         Med 1999; 245(3): 307-10.
 

FDA Warns Against Drug Promotion of "Herbal Fenphen."  In:  FDA Talk Paper Rockville, MD: 
         Department of Health and Human Services, Food and Drug Administration, Nov. 6, 1997.  Retrieved
         February 2002 from the World Wide Web:         
         Http://www.fda.gov/bbs/topics/ANSWERS/ANS00832.html.

 

FDA Issues Regulation Prohibiting Sale of Dietary Supplements Containing Ephedrine Alkaloids and Reiterates Its Advice That Consumers Stop Using These Products. Retrieved March 2004 from the World Wide Web:                     

         http://www.fda.gov/bbs/topics/NEWS/2004/NEW01021.html

 

Farmer WD, Silverman DG.  Potential Effects of Herbal Medicinals on Perioperative Care.  Seminars in
         Anesthesia, Perioperative Medicine, and Pain 2001; 20(2).
 

Gardiner, P, Phillips, R, Shaugnessy, A. Herbal and Dietary Supplement-Drug Interactions in Patients with Chronic

         Illnesses. American Family Physician. 2008. 77(1)73-78.

 

Gilbert GJ.  Gingko biloba (Letter).  Neurology 1997; 48: 1137.
 

Haller CA, Benowitz NL.  Adverse Cardiovascular and Central Nervous System Events Associated with
         Dietary Supplements Containing Ephedra Alkaloids.  N Engl J Med 2000; 343(25):1833-8.
 

Kumar, NB, Allen, K, Bell H.  Perioperative Herbal Supplement Use in Cancer Patients: Potential implications and

        Recommendations for Presurgical Screening.  Cancer Control July 2005. 12(3):149-157. 

 

Leung JM, Dzankic S, Kawalpreet M.  The Prevalence and Predictors of the Use of Alternative Medicine
         in Presurgical Patients in Five California Hospitals.  Anesth Analg 2001; 93(4): 1062-8.
 

Matthews MK Jr.  Association of Ginkgo biloba with Intracerebral Hemorrhage (Letter).  Neurology 1998,
         50:1993-4.
 

Nelson L, Perrone J.  Pharmacologic Advances in Emergency Medicine:  Herbal and Alternative
         Medicine.  Emerg clin North Am 2000; 18(4): 709-22.
 

Norred CL, Brinker F.  Potential Coagulation Effects of Preoperative Complementary and Alternative
         Medicines.  Alternative Therapies 2001; 7(6): 58-67.
 

Page RL II, Lawrence JD.  Potentiation of Warfarin by Dong Quai.  Pharmacotherapy 1999; 19(7): 870-6.
 

Powell T, Hsu FF, Turk J, Hruska K.  Ma-huang Strikes Again: Ephedrine Nephrolithiasis.  Am J Kidney
         Disease 1998; 32:153-9.
 

Professional Guide to Conditions, Herbs & Supplements.  Quick Access.  2000 Integrative Medicine Communications. 
     www.onemedicine.com 
 

Richardson, MA.  Biopharmacologic and Herbal Therapies for Cancer: Research Updatefrom NCCAM.  Journal of Nutrition 2001.  Research Update from the NCCAM.

 

Rosenblatt M, Mindel J. Spontaneous Hyphema Associated with Ingestion of Ginkgo biloba Extract        
         (Letter).  N Engl J Med 1997; 336:1108.             
 

Rowin J, Lewis SL.  Spontaneous Bilateral Subdural Hematomas Associated with Chronic Ginkgo biloba
         Ingestion.  Neurology 1996; 46: 1775-6.
 

Russo S.  Low Doses of Liquorice Can Induce Hypertension Encephalopathy.  Am J Nephorl 2000; 20(2):
         145-8.
 

Samenuk K, Link MS, Homoud MK, Contreras R, Theohardes TC, Wang PJ, Estes NA III.  Adverse
         Cardiovascular Events Temporally Associated with Ma Huang, an Herbal Source of Ephedrine.         
         Mayo Clin Proc 2002; 77(1):12-6.
 

Schelosky L, Raffauf C, Jendroska K, Poewe W.  Kava and Dopamine Antagonism (Letter).  J Neurol
         Neuro-surg Psychiatry 1995; 58: 639-40.
 

Shaw HS, Kroll DJ.  the Convergence of Herb Pharmacodynamics and Herb-Drug Interactions on
         Hemostasis.  Alternative Therapies 2001; 7(6): 46-7.
 

Sigurjonsdottir HA.  Liquorice-induced Rise in Blood Pressure:  A Linear Dose-Response Relationship.  J
         Hum Hypertens 2001; 15(8): 549-52.
 

Spell NO III.  Postoperative Medical Complications:  Stopping and Restarting Medications in the
         Perioperative Period.  Med Clin North Am 2001; 85(5).
 

Tsen CL, Segal S, Pothier M, Bader AM.  Alternative Medicine Use in Presurgical Patients. 
         Anesthesiology 2000: 93(1).
 

Stewart PM.  Mineralocorticoid Activity of Liquorice:  11-beta-hydroxysteroid dehydrogenase Deficiency
         Comes of Age.  Lancet 1987; 2(8563): 821-4.
 

Ulick S.  A Syndrome of Apparent Mineralocorticoid Excess Associated with Defects in the Peripheral
         Metabolism of Cortisol.  J Clin Endocrinol Metab 1979;  49(5): 757-64.
 

Vaes LP, Chyka PA.  Interactions of Warfarin with Garlic, Ginger, Ginkgo, or Ginseng:  Nature of the
         Evidence.  Ann Pharmacother 2000; 34(12): 1478-82.
 

White LM, Gardner SF, Gurley BJ, Marx MA, Wang PL, Estes M.  Pharmacokinetics and Cardiovascular

         Effects of Ma-huang (Ephedra sinica) in Normotensive Adults.  J Clin Pharmacol 1997;
         37(2):116-22.